Global and Japan Cardiopulmonary Autotransfusion System Market Insights, Forecast to 2027

Publisher Name :
Date: 01-Sep-2021
No. of pages: 134
Inquire Before Buying

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Market Analysis and Insights: Global and Japan Cardiopulmonary Autotransfusion System Market

This report focuses on global and Japan Cardiopulmonary Autotransfusion System market.

In 2020, the global Cardiopulmonary Autotransfusion System market size was US$ 540 million and it is expected to reach US$ 637.6 million by the end of 2027, with a CAGR of 2.4% during 2021-2027. In Japan the Cardiopulmonary Autotransfusion System market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Cardiopulmonary Autotransfusion System Scope and Market Size

Cardiopulmonary Autotransfusion System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Autotransfusion System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Cardiopulmonary Autotransfusion System market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Unwashed ATS

- Washed ATS

Segment by Application

- Heart Surgery

- Great Organ Transplant Surgery

- Other Surgery

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Haemonetics

- Medtronic

- LivaNova

- Fresenius Kabi

- Terumo

- Wandong Health Sources

Global and Japan Cardiopulmonary Autotransfusion System Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Cardiopulmonary Autotransfusion System Product Introduction
1.2 Market by Type
1.2.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Other Surgery
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Autotransfusion System Market Size, Estimates and Forecasts
2.1.1 Global Cardiopulmonary Autotransfusion System Revenue 2016-2027
2.1.2 Global Cardiopulmonary Autotransfusion System Sales 2016-2027
2.2 Global Cardiopulmonary Autotransfusion System, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cardiopulmonary Autotransfusion System Historical Market Size by Region (2016-2021)
2.3.1 Global Cardiopulmonary Autotransfusion System Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cardiopulmonary Autotransfusion System Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cardiopulmonary Autotransfusion System Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cardiopulmonary Autotransfusion System Sales Forecast by Region (2022-2027)
2.4.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Region (2022-2027)
3 Global Cardiopulmonary Autotransfusion System Competitor Landscape by Players
3.1 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Sales
3.1.1 Global Cardiopulmonary Autotransfusion System Sales by Manufacturer (2016-2021)
3.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Revenue
3.2.1 Key Cardiopulmonary Autotransfusion System Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2016-2021)
3.2.3 Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cardiopulmonary Autotransfusion System Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion System Revenue in 2020
3.2.6 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cardiopulmonary Autotransfusion System Price by Manufacturers
3.4 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Product Types
3.4.1 Cardiopulmonary Autotransfusion System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cardiopulmonary Autotransfusion System Product Type
3.4.3 Date of International Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Cardiopulmonary Autotransfusion System Market Size by Type (2016-2021)
4.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2016-2021)
4.1.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2016-2021)
4.1.3 Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cardiopulmonary Autotransfusion System Market Size Forecast by Type (2022-2027)
4.2.1 Global Cardiopulmonary Autotransfusion System Sales Forecast by Type (2022-2027)
4.2.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Type (2022-2027)
4.2.3 Cardiopulmonary Autotransfusion System Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Cardiopulmonary Autotransfusion System Market Size by Application (2016-2021)
5.1.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2016-2021)
5.1.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2016-2021)
5.1.3 Cardiopulmonary Autotransfusion System Price by Application (2016-2021)
5.2 Cardiopulmonary Autotransfusion System Market Size Forecast by Application (2022-2027)
5.2.1 Global Cardiopulmonary Autotransfusion System Sales Forecast by Application (2022-2027)
5.2.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Application (2022-2027)
5.2.3 Global Cardiopulmonary Autotransfusion System Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
6.1.1 Japan Cardiopulmonary Autotransfusion System Sales YoY Growth 2016-2027
6.1.2 Japan Cardiopulmonary Autotransfusion System Revenue YoY Growth 2016-2027
6.1.3 Japan Cardiopulmonary Autotransfusion System Market Share in Global Market 2016-2027
6.2 Japan Cardiopulmonary Autotransfusion System Market Size by Players (International and Local Players)
6.2.1 Japan Top Cardiopulmonary Autotransfusion System Players by Sales (2016-2021)
6.2.2 Japan Top Cardiopulmonary Autotransfusion System Players by Revenue (2016-2021)
6.3 Japan Cardiopulmonary Autotransfusion System Historic Market Review by Type (2016-2021)
6.3.1 Japan Cardiopulmonary Autotransfusion System Sales Market Share by Type (2016-2021)
6.3.2 Japan Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2016-2021)
6.3.3 Japan Cardiopulmonary Autotransfusion System Price by Type (2016-2021)
6.4 Japan Cardiopulmonary Autotransfusion System Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Cardiopulmonary Autotransfusion System Sales Forecast by Type (2022-2027)
6.4.2 Japan Cardiopulmonary Autotransfusion System Revenue Forecast by Type (2022-2027)
6.4.3 Japan Cardiopulmonary Autotransfusion System Price Forecast by Type (2022-2027)
6.5 Japan Cardiopulmonary Autotransfusion System Historic Market Review by Application (2016-2021)
6.5.1 Japan Cardiopulmonary Autotransfusion System Sales Market Share by Application (2016-2021)
6.5.2 Japan Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2016-2021)
6.5.3 Japan Cardiopulmonary Autotransfusion System Price by Application (2016-2021)
6.6 Japan Cardiopulmonary Autotransfusion System Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Cardiopulmonary Autotransfusion System Sales Forecast by Application (2022-2027)
6.6.2 Japan Cardiopulmonary Autotransfusion System Revenue Forecast by Application (2022-2027)
6.6.3 Japan Cardiopulmonary Autotransfusion System Price Forecast by Application (2022-2027)
7 North America
7.1 North America Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
7.2 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
7.2.1 North America Cardiopulmonary Autotransfusion System Sales by Country (2016-2021)
7.2.2 North America Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Region
8.2.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2016-2021)
8.2.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
9.2 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
9.2.1 Europe Cardiopulmonary Autotransfusion System Sales by Country (2016-2021)
9.2.2 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
10.2 Latin America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
10.2.1 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2016-2021)
10.2.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
11.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Haemonetics
12.1.1 Haemonetics Corporation Information
12.1.2 Haemonetics Description and Business Overview
12.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Haemonetics Cardiopulmonary Autotransfusion System Products Offered
12.1.5 Haemonetics Recent Development
12.2 Medtronic
12.2.1 Medtronic Corporation Information
12.2.2 Medtronic Description and Business Overview
12.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Medtronic Cardiopulmonary Autotransfusion System Products Offered
12.2.5 Medtronic Recent Development
12.3 LivaNova
12.3.1 LivaNova Corporation Information
12.3.2 LivaNova Description and Business Overview
12.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LivaNova Cardiopulmonary Autotransfusion System Products Offered
12.3.5 LivaNova Recent Development
12.4 Fresenius Kabi
12.4.1 Fresenius Kabi Corporation Information
12.4.2 Fresenius Kabi Description and Business Overview
12.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Products Offered
12.4.5 Fresenius Kabi Recent Development
12.5 Terumo
12.5.1 Terumo Corporation Information
12.5.2 Terumo Description and Business Overview
12.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Terumo Cardiopulmonary Autotransfusion System Products Offered
12.5.5 Terumo Recent Development
12.6 Wandong Health Sources
12.6.1 Wandong Health Sources Corporation Information
12.6.2 Wandong Health Sources Description and Business Overview
12.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Products Offered
12.6.5 Wandong Health Sources Recent Development
12.11 Haemonetics
12.11.1 Haemonetics Corporation Information
12.11.2 Haemonetics Description and Business Overview
12.11.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Haemonetics Cardiopulmonary Autotransfusion System Products Offered
12.11.5 Haemonetics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cardiopulmonary Autotransfusion System Industry Trends
13.2 Cardiopulmonary Autotransfusion System Market Drivers
13.3 Cardiopulmonary Autotransfusion System Market Challenges
13.4 Cardiopulmonary Autotransfusion System Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cardiopulmonary Autotransfusion System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Unwashed ATS
Table 3. Major Manufacturers of Washed ATS
Table 4. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application (2021-2027) & (Units)
Table 5. Global Cardiopulmonary Autotransfusion System Market Size by Region (Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Cardiopulmonary Autotransfusion System Sales by Regions (2016-2021) & (Units)
Table 7. Global Cardiopulmonary Autotransfusion System Sales Market Share by Regions (2016-2021)
Table 8. Global Cardiopulmonary Autotransfusion System Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Cardiopulmonary Autotransfusion System Sales Forecast by Region (2022-2027) & (Units)
Table 10. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Cardiopulmonary Autotransfusion System Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Cardiopulmonary Autotransfusion System Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Cardiopulmonary Autotransfusion System Sales by Manufacturers (2016-2021) (Units)
Table 14. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Cardiopulmonary Autotransfusion System Manufacturers by Revenue (US$ Million) in 2020
Table 16. Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2016-2021)
Table 18. Global Cardiopulmonary Autotransfusion System Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2020)
Table 20. Key Manufacturers Cardiopulmonary Autotransfusion System Price (2016-2021) (K US$/Unit)
Table 21. Cardiopulmonary Autotransfusion System Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cardiopulmonary Autotransfusion System Product Type
Table 23. Date of International Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Cardiopulmonary Autotransfusion System Sales by Type (2016-2021) (Units)
Table 26. Global Cardiopulmonary Autotransfusion System Sales Share by Type (2016-2021)
Table 27. Global Cardiopulmonary Autotransfusion System Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Cardiopulmonary Autotransfusion System Revenue Share by Type (2016-2021)
Table 29. Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Type (2016-2021) & (K US$/Unit)
Table 30. Global Cardiopulmonary Autotransfusion System Sales Forecast by Type (2022-2027) & (Units)
Table 31. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Cardiopulmonary Autotransfusion System Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Cardiopulmonary Autotransfusion System Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Cardiopulmonary Autotransfusion System Average Selling Price (ASP) Forecast by Type (2022-2027) & (K US$/Unit)
Table 35. Global Cardiopulmonary Autotransfusion System Sales by Application (2016-2021) (Units)
Table 36. Global Cardiopulmonary Autotransfusion System Sales Share by Application (2016-2021)
Table 37. Global Cardiopulmonary Autotransfusion System Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Cardiopulmonary Autotransfusion System Revenue Share by Application (2016-2021)
Table 39. Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Application (2016-2021) & (K US$/Unit)
Table 40. Global Cardiopulmonary Autotransfusion System Sales Forecast by Application (2022-2027) & (Units)
Table 41. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Cardiopulmonary Autotransfusion System Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Cardiopulmonary Autotransfusion System Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Cardiopulmonary Autotransfusion System Average Selling Price (ASP) Forecast by Application (2022-2027) & (K US$/Unit)
Table 45. Japan Cardiopulmonary Autotransfusion System Sales (Units) of Key Companies (2016-2021)
Table 46. Japan Cardiopulmonary Autotransfusion System Sales Share by Company (2016-2021)
Table 47. Japan Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Cardiopulmonary Autotransfusion System Revenue Share by Company (2016-2021)
Table 49. Japan Cardiopulmonary Autotransfusion System Sales (Units) by Type (2016-2021)
Table 50. Japan Cardiopulmonary Autotransfusion System Sales Share by Type (2016-2021)
Table 51. Japan Cardiopulmonary Autotransfusion System Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Type (2016-2021)
Table 53. Japan Cardiopulmonary Autotransfusion System Sales (Units) by Type (2022-2027)
Table 54. Japan Cardiopulmonary Autotransfusion System Sales Share by Type (2022-2027)
Table 55. Japan Cardiopulmonary Autotransfusion System Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Cardiopulmonary Autotransfusion System Revenue Share by Type (2022-2027)
Table 57. Japan Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Type (2022-2027)
Table 58. Japan Cardiopulmonary Autotransfusion System Sales (Units) by Application (2016-2021)
Table 59. Japan Cardiopulmonary Autotransfusion System Sales Share by Application (2016-2021)
Table 60. Japan Cardiopulmonary Autotransfusion System Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Application (2016-2021)
Table 62. Japan Cardiopulmonary Autotransfusion System Sales (Units) by Application (2022-2027)
Table 63. Japan Cardiopulmonary Autotransfusion System Sales Share by Application (2022-2027)
Table 64. Japan Cardiopulmonary Autotransfusion System Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Cardiopulmonary Autotransfusion System Revenue Share by Application (2022-2027)
Table 66. Japan Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Application (2022-2027)
Table 67. North America Cardiopulmonary Autotransfusion System Sales by Country (2016-2021) & (Units)
Table 68. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2016-2021)
Table 69. North America Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2016-2021) & (Units)
Table 72. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2016-2021)
Table 75. Europe Cardiopulmonary Autotransfusion System Sales by Country (2016-2021) & (Units)
Table 76. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2016-2021)
Table 77. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2016-2021)
Table 79. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2016-2021) & (Units)
Table 80. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2016-2021) & (Units)
Table 84. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2016-2021)
Table 87. Haemonetics Corporation Information
Table 88. Haemonetics Description and Business Overview
Table 89. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 90. Haemonetics Cardiopulmonary Autotransfusion System Product
Table 91. Haemonetics Recent Development
Table 92. Medtronic Corporation Information
Table 93. Medtronic Description and Business Overview
Table 94. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 95. Medtronic Product
Table 96. Medtronic Recent Development
Table 97. LivaNova Corporation Information
Table 98. LivaNova Description and Business Overview
Table 99. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 100. LivaNova Product
Table 101. LivaNova Recent Development
Table 102. Fresenius Kabi Corporation Information
Table 103. Fresenius Kabi Description and Business Overview
Table 104. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 105. Fresenius Kabi Product
Table 106. Fresenius Kabi Recent Development
Table 107. Terumo Corporation Information
Table 108. Terumo Description and Business Overview
Table 109. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 110. Terumo Product
Table 111. Terumo Recent Development
Table 112. Wandong Health Sources Corporation Information
Table 113. Wandong Health Sources Description and Business Overview
Table 114. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 115. Wandong Health Sources Product
Table 116. Wandong Health Sources Recent Development
Table 117. Cardiopulmonary Autotransfusion System Market Trends
Table 118. Cardiopulmonary Autotransfusion System Market Drivers
Table 119. Cardiopulmonary Autotransfusion System Market Challenges
Table 120. Cardiopulmonary Autotransfusion System Market Restraints
Table 121. Cardiopulmonary Autotransfusion System Customers List
Table 122. Cardiopulmonary Autotransfusion System Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiopulmonary Autotransfusion System Product Picture
Figure 2. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type in 2020 & 2027
Figure 3. Unwashed ATS Product Picture
Figure 4. Washed ATS Product Picture
Figure 5. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application in 2020 & 2027
Figure 6. Heart Surgery
Figure 7. Great Organ Transplant Surgery
Figure 8. Other Surgery
Figure 9. Cardiopulmonary Autotransfusion System Report Years Considered
Figure 10. Global Cardiopulmonary Autotransfusion System Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cardiopulmonary Autotransfusion System Market Size 2016-2027 (US$ Million)
Figure 12. Global Cardiopulmonary Autotransfusion System Sales 2016-2027 (Units)
Figure 13. Global Cardiopulmonary Autotransfusion System Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2016-2021)
Figure 15. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region in 2020
Figure 16. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2016-2021)
Figure 17. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region in 2020
Figure 18. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Cardiopulmonary Autotransfusion System Revenue in 2020
Figure 20. Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2016-2021)
Figure 22. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type in 2020
Figure 23. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2016-2021)
Figure 24. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type in 2020
Figure 25. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2016-2021)
Figure 26. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application in 2020
Figure 27. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2016-2021)
Figure 28. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application in 2020
Figure 29. Japan Cardiopulmonary Autotransfusion System Sales Growth Rate 2016-2027 (Units)
Figure 30. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan Cardiopulmonary Autotransfusion System Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest Cardiopulmonary Autotransfusion System Players Market Share by Revenue in Cardiopulmonary Autotransfusion System in 2020
Figure 33. Japan Cardiopulmonary Autotransfusion System Revenue Share by Type (2016-2021)
Figure 34. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan Cardiopulmonary Autotransfusion System Revenue Share by Application (2016-2021)
Figure 36. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Cardiopulmonary Autotransfusion System Sales Growth Rate 2016-2021 (Units)
Figure 38. North America Cardiopulmonary Autotransfusion System Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country in 2020
Figure 40. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Country in 2020
Figure 41. U.S. Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 42. U.S. Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 44. Canada Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Cardiopulmonary Autotransfusion System Sales Growth Rate 2016-2021 (Units)
Figure 46. Europe Cardiopulmonary Autotransfusion System Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country in 2020
Figure 48. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country in 2020
Figure 49. Germany Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 50. Germany Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 52. France Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 54. U.K. Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 56. Italy Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 58. Russia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Cardiopulmonary Autotransfusion System Sales Growth Rate 2016-2021 (Units)
Figure 60. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Region in 2020
Figure 62. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Region in 2020
Figure 63. China Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 64. China Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 66. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 68. South Korea Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 70. India Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 72. Australia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 74. China Taiwan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Cardiopulmonary Autotransfusion System Sales Growth Rate (2016-2021) (Units)
Figure 76. Indonesia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2016-
  • Global Cardiac Care Medical Equipment Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 90
    Cardiac Care Medical Equipment is The equipment used for cardiac care. The robust line of cardiac care products include Cardiac Monitors, EKG (Electrocardiogram) Equipment, Heart-Lung Bypass Machines, Stress Test Systems, Intra-Aortic Balloon Pumps, Infusion Pumps, AEDs and Defibrillators, and more. The global Cardiac Care Medical Equipment market was valued at US$ 27110 million in 2023 and is anticipated to reach US$ 41790 million by 2030, witnessing a CAGR of 6.3% during The forec......
  • Global Intra-Aortic Balloon Pump (IABP) Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 70
    Intra-Aortic Balloon Pump, or IABP for short, is a mechanically assisted circulatory device that is currently widely used in clinical practice. A catheter with a balloon is implanted in The arterial system to The distal end of The left subclavian artery opening in The descending aorta. The filling, expansion and emptying corresponding to The cardiac cycle can cause The blood to undergo phasic changes in The aorta, thereby playing The role of mechanically assisting The circulation of a cardiac ca......
  • Global Cardiopulmonary Autotransfusion System Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Cardiopulmonary Autotransfusion System market size was valued at US$ 541 million in 2023. With growing demand in downstream market, the Cardiopulmonary Autotransfusion System is forecast to a readjusted size of US$ 642.6 million by 2030 with a CAGR of 2.5% during review period. The research report highlights the growth potential of the global Cardiopulmonary Autotransfusion System market. Cardiopulmonary Autotransfusion Syste......
  • Global Cardiac Pacing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Cardiac Pacing market size was valued at US$ 10540 million in 2023. With growing demand in downstream market, the Cardiac Pacing is forecast to a readjusted size of US$ 11650 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Cardiac Pacing market. Cardiac Pacing are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Transcatheter Aortic Valve Replacement (TAVR) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Transcatheter Aortic Valve Replacement (TAVR) market size was valued at US$ 3921.4 million in 2023. With growing demand in downstream market, the Transcatheter Aortic Valve Replacement (TAVR) is forecast to a readjusted size of US$ 12070 million by 2030 with a CAGR of 17.4% during review period. The research report highlights the growth potential of the global Transcatheter Aortic Valve Replacement (TAVR) market. Transcathete......
  • Global Cardiac Care Medical Equipment Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Cardiac Care Medical Equipment market size was valued at US$ 26520 million in 2023. With growing demand in downstream market, the Cardiac Care Medical Equipment is forecast to a readjusted size of US$ 41310 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Cardiac Care Medical Equipment market. Cardiac Care Medical Equipment are expected to show stable ......
  • Global Peripheral Vascular Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Peripheral Vascular Devices market size was valued at US$ 6120.9 million in 2023. With growing demand in downstream market, the Peripheral Vascular Devices is forecast to a readjusted size of US$ 8023.3 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Peripheral Vascular Devices market. Peripheral Vascular Devices are expected to show stable growth in ......
  • Global Interventional Cardiology Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Interventional Cardiology market size was valued at US$ 3088.3 million in 2023. With growing demand in downstream market, the Interventional Cardiology is forecast to a readjusted size of US$ 3773.7 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Interventional Cardiology market. Interventional Cardiology are expected to show stable growth in the futu......
  • Global Diagnostic Electrocardiograph (ECG) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Diagnostic Electrocardiograph (ECG) market size was valued at US$ 5416.8 million in 2023. With growing demand in downstream market, the Diagnostic Electrocardiograph (ECG) is forecast to a readjusted size of US$ 7611.5 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Diagnostic Electrocardiograph (ECG) market. Diagnostic Electrocardiograph (ECG) are ex......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs